INTRODUCTION
Burn is a posttraumatic inflammatory disease accompanied by both local and distant effects leading to intense inflammation, tissue damage, and infection. [1] Although a considerable progress in the management of burns has been achieved, systemic inflammatory response syndrome (SIRS), sepsis, and multiple been defined as a process induced by injury that normally leads to healing and is an essential component of physiological and /or pathological angiogenesis in most organs. Inflammatory cells surrounding the microvasculature can have a profound effect on promoting new vessel growth via vascular endothelial growth factor (VEGF) and VEGF receptors such as VEGF Receptor-1 (Flt-1). [17] [18] [19] However, the roles of VEGF and VEGF decoy receptor Flt-1 in pathophysiological events, such as oxidative and nitrosative damage secondary to inflammation, are still in the area of active research. [17, [19] [20] [21] [22] [23] [24] Effects of different agents on oxidative damage due to severe burn injury were evaluated in remote organs such as the lung, liver, gut and kidney in previous studies. [4, 9, [25] [26] [27] [28] Sildenafil is known as a selective and potent inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase-5 (PDE-5). PDE-5 catalyzes the hydrolysis of cGMP. Inhibition of PDE-5 causes increased concentration of cGMP and cyclic adenosine monophosphate (cAMP). The cyclic nucleotides cAMP and cGMP are second messengers playing major roles in various cellular processes, such as inflammation. [29] Sildenafil induces endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) generating nitric oxide (NO). Thus, sildenafil has a relaxant effect on smooth muscle cells of the arterioles and via NO dependent mechanism and may induce blocking of VEGF activity by a neutralized antibody against VEGF receptors as well as augment angiogenesis. [23] However, most of these effects appear to be dosage dependent due to the levels of generated NO. [20] Moreover, the beneficial effects of sildenafil have been shown in the balance of oxidation and antioxidation via decreasing oxidative and nitrosative stress in inflammatory events. [9, 23, [30] [31] [32] [33] [34] However, there is no study in the literature focusing on the effects of sildenafil in remote organ injury induced by severe burn except our previous study focusing on acute lung injury. [9] The purpose of the present study was to evaluate the effects of different dosages of sildenafil in distant organs, such as liver and kidneys, due to severe scald burn injury in rats.
MATERIALS AND METHODS
The research was conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication no. 85-23, revised 1996) and approval has been received from the Institutional Animal Ethics Committee at Cumhuriyet University.
Animals
A total of thirty-two adult female Wistar Albino rats weighing between 200-250 g were included in the study. Animals were provided by the Experimental Animals Center, Cumhuriyet University, Sivas, Turkey. The animals were fed ad libitum with standard diet and water throughout the experiment. All animals were housed separately and kept under standard conditions of room temperature (22-24 °C) and a 12 h light/12 h dark cycle.
Burn Procedure
Animals were anesthetized with (i.p.) xylazine (5 mg/kg) and ketamine (30 mg/kg) during the scalding and burn procedure, and 1 mg/kg morphine was administered intra-muscular just before immersing each of them to the boiling water. The dorsal surfaces of the rats were shaved closely, and the rats were secured in a constructed template device. The surface area of the skin on the dorsal surface exposed through the template device was immersed in 98 °C water for 12 s. All test animals were quickly dried after each exposure to avoid additional injury. With the use of this technique, full-thickness dermal burns comprising 30% of the total body surface area (TBSA) were obtained. [25] 
Chemicals
All the chemicals used in the experiments were purchased from Sigma Chemical Co. (Munich, Germany) except for Sildenafil which was obtained from Pfizer (Istanbul, Turkey).
Experimental Design
Animals were randomly divided into four equal groups as follows: Group S (no burn, no medication), Group C (scald control) was administrated per orally (p.o) 2 ml 0.09% NaCl, Group T10 (Treatment with sildenafil 10 mg/kg): 10 mg/kg p.o sildenafil, and Group T20 (Treatment with sildenafil 20 mg/kg): 20 mg/kg p.o. sildenafil just after the scald burn. All animals were administered 4 ml/100 g body weight of lactated Ringer's solution subcutaneously just after the burn injury for fluid resuscitation according to parkland formula. Later, all animals were located in their own cages and let free to reach food and water. The reason for the selection of 10 and 20 mg/kg doses of oral sildenafil was that 10 mg/kg/day of sildenafil would result approximately in the same plasma concentration as 50 mg in humans.
[35] These doses are very common for rats and our first aim was to determine whether it was protective in burn induced organ damage, as well as how the dose affected protection. All animals were sacrificed at the 24th hour after the scald burn via an overdose of a general anesthetic (thiopental sodium, 50 mg/ kg). Blood samples of the animals were collected in tubes for biochemical analysis, and liver and kidneys were harvested from all rats and washed in ice cold saline.
Half of the tissues were transferred to the biochemistry laboratory to be kept at -80°C for biochemical analyses and the other half were fixed in 10% formalin solution for histopathological analysis.
Levels of malondialdehyde (MDA), VEGF, Flt-1, the activities of glutathione peroxidase (Gpx), levels of total antioxidative capacity (TAC), and total oxidant status (TOS) were measured in both tissue and serum. Oxidative stress index (OSI) was also calculated in tissue and serum. Additionally, ratios of VEGF/Flt-1 in tissue and serum were calculated. A semiquantitative scoring system was used for the evaluation of histopathological findings which was used in our previous study [9] (Table 1) .
Biochemical Investigation of the Tissues
In order to prepare the tissue homogenates, tissues were ground with liquid nitrogen in a mortar. The ground tissues (0.5 g each) were then treated by 1 ml of homogenization buffer per 100 mg of tissue. The mixtures were homogenized on ice using an Ultra-Turrax Homogenizer for 15 min. The homogenates were filtered and centrifuged, using a refrigerated centrifuge at 10,000 x g for 15 min at 4°C. Supernatants and assay samples were collected according to the kit booklet protocol. All assays were performed at room temperature in duplicate.
Biochemical Investigation of the Serum
Blood was collected without using an anticoagulant, and then was allowed to clot for 30 min at 25°C. Afterwards, blood samples were centrifuged at 2,000 x g for 15 min at 4°C, and serum layers were pipetted off without disturbing the white buffy layers. Subsequently, serums were stored on ice and samples were frozen at -80°C.
Measurement of MDA, Gpx, VEGF, and Flt-1
All analyses were made for each parameter according to the protocols of each kit manufacturer's requirements.
As an index of lipid peroxidation and free radical generation, MDA content in the tissue supernatant and serum was measured by the MDA-586 method using a Bioxytech MDA-586 assay kit (Oxis Research, Oregon, USA). [36] Protein concentration was determined by the Beckman Protein Assay on a Synchron ® l x 20 analyzer (Beckman Coulter, 95942 Villepointe-Roissy-CDG, France) using BSA as a standard. MDA levels in the tissue supernatant were normalized against protein (pmol/g). Gpx was measured as a marker of enzymatic defense against ROS. Gpx activity in tissues and blood were measured spectrophotometrically using Cayman's standard glutathione (GSH) assay kit (Cayman Chemical Company, Ann Arbor, MI, USA). [37] Gpx activity in tissue supernatant was normalized against protein (nmol/min/g). VEGF and Flt-1 were measured in both serum and tissues in order to identify the effects of sildenafil in vascular permeability as well as angiogenesis and inflammation. Concentrations of VEGF and Flt-1 were measured using two ELISA kits (RayBiotech. Inc., Norcross, GA, USA and Cusabio Biotech Co., Wuhan, Hubei Province, China). Values were calculated and converted to picograms per gram for tissues (pg/g), and picograms per milliliter for serum (pg/ml ). [21, 22] Ratios of VEGF/Flt-1 in tissues and serum were calculated in order to evaluate the local and systemic effects of sildenafil in the NO -VEGF/Flt-1 relationship and assess the correlation between histopathologic findings and VEGF/Flt-1 ratios.
Measurement of TOS, TAC, and OSI
TOS and TAC levels were measured using a spectrophotometric kit (Rel Assay Diagnostics, Gaziantep, Turkey,). [38, 39] Levels of TOS and TAC were assayed in an autoanalyzer (Beckman Coulter LX 20, Inc., Fullerton, CA, USA). Results of serum levels were expressed as millimolar Trolox (Rel Assay Diagnostics) equivalent per liter (L). TOS and TAC levels in the tissue supernatants were normalized against protein (mmol Trolox Equiv/g). The ratio of TOS to TAC was accepted as the OSI.
Histopathological Evaluation of the Specimens
Tissue samples were fixed in 10% buffered formalin for two days. Later each liver and kidney tissue samples were processed routinely and embedded in paraffin. After embedding, 5-µm thick sections were taken from the tissue blocks and stained with hematoxylin and eosin (HE). Light microscope (X260) was used for histopathologic examination. The degree of the inflammation and destruction were scored for each group (Table 1) . A pathologist unaware of the group assignment analyzed samples. A mean score for each of the variables was then calculated. A total histopathological score (maximum 14) was derived from the sum of the mean scores of the four variables. All the samples were reviewed by the same pathologist to achieve correct score and mean value of each group was used for statistical analysis.
Statistical Analysis
Statistical analysis was performed with the Statistical Package for the Social Sciences for Windows (SPSS version 15.0, Chicago, IL, USA). All values were expressed as mean ± standard deviation (SD). Comparison of variables between the groups was performed with Kruskal-Wallis test and Mann-Whitney 
RESULTS
During the experimental period, only one death was observed in Group C and was seen in the first 12 h. There was no statistically significant difference in mortality between groups.
Levels of MDA, Gpx, VEGF, Flt-1, TAC, TOS and OSI in Liver Tissues
Liver tissue levels of MDA, Gpx, VEGF, Flt-1, TAC, TOS and OSI were exhibited in Table 2 . The lowest MDA levels were detected in Group S and Group T10 (1.15±0.95 and 1.08±0.37 pmol/g /tissue, respectively). Significant differences were found between Group S and Group C (p=0.002), and between Group C and Group T10 (p=0,009).
The highest increase was detected in Group T10 (9.52±1.48 nmol/min/g/tissue) in terms of Gpx levels and this increase rate was statistically different when compared to Group C (p=0.04) and Group T20 (p=0.017); however, no difference was detected between Group T10 and Group S.
There was a significant increase in VEGF levels in Group T10 when compared to Group S (0.003), Group C (0.018), and Group T20 (0.001). Interestingly enough, VEGF levels were lower in Group T20 than in Group C, but this increase was not statistically significant (p=0.179). A trend of increase was found in Flt-1 levels in treatment groups, but there was only a significant difference between Group C and Group T20 (p=0.001).
TAC levels were detected significantly higher in Group S than in Group C (0.001), Group T10 (0.002), and Group T20 (0.002). Also, TAC levels were statistically higher in Group T10 than in Group C (p=0.009). There was no difference between the four groups in terms of TOS levels. OSI levels were detected in significantly lower levels in Group T10 (p=0.008) than in Group C. and OSI were exhibited in Table 3 . The lowest MDA levels were detected in Group S (1.09±0.16) and in Group T10 (1.26±0.11 pmol/g /tissue). There was a statistically significant difference between Group C and T10 and T20 Groups (p=0.001 and p=0.034); whereas a similar significant difference was detected between T10 and T20 Groups (p=0.001).
The highest increase was detected in group T10 (6.733±1.33 nmol/min/g/tissue) in terms of Gpx levels and this increase rate in Group T10 was statistically different when compared to Group C (p=0.006); also, Gpx levels were significantly higher in Group T20 (p=0.018) than in Group C; however, no difference was detected between Group T10 and Group T20.
There were significant decreases in VEGF levels in Group T10 (p=0.026) and Group T20 (p=0.003) compared to Group C; however, no statistical difference was found between Groups T10 and T20. Flt-1 levels were significantly higher in Group T10 than in Group C (p=0.013), and Group T20 (p=0.022), but no difference was found between Group C and Group T20.
There were no differences between the groups in terms of TAC, TOS and OSI levels except only in Group T20 whose TOS levels were detected lower than in Group C (p=0.028).
Levels of MDA, VEGF, Flt-1, Gpx, TAC, TOS, and OSI in Serum Levels of MDA, Gpx, VEGF, Flt-1, VEGF/Flt-1, TAC, TOS, and OSI in serum were shown in Table 4 . MDA levels were the lowest in Groups S (1,27±0,24) and T10 (1,54±0,39) and it was significant when compared to Group C (p=0,001). There were no differences between Groups T10 and T20.
Gpx levels were significantly higher in Group T10 when compared to Group C (p=0.001) and Group T20 (p=0.004). There were no differences between groups in terms of VEGF and Flt-1 levels. However, the Flt-1/VEGF ratios were sig- nificantly higher in Group T10 (p=0.25) than in Groups C (p=0.025) and T20 (p=0.029).
Levels of TAC were higher in Group T10 than in Groups C (p=0.001) and T20 (p=0.004). TOS levels decreased significantly in Group T10 compared to Groups C (p=0.001) and T20 (p=0.002). OSI levels decreased significantly in Group T10 compared to Groups C (p=0.001) and T20 (p=0.001).
Histopathological Findings
Histopathological scores in livers and kidneys were shown in (Table 5 ). Histopathological scores of the liver was found statistically lower in Group T10 (p=0.006) compared to group C (Fig. 1) , and this score was also lower in Group T20 when compared to Group C; however, it was not statistically significant. Histopathological scores of the kidneys were significantly lower in Group T10 compared to Groups C (p=0.001) and T20 (p=0.003); whereas no difference was detected between Groups T10 and T20 (Fig. 2) .
The Correlation of VEGF, Flt-1, and VEGF/Flt-1 Ratios in Tissue and Serum
With Histopathological Findings
The correlation between the liver, kidney and serum values of VEGF, Flt-1, and VEGF/Flt-1 ratios and histopathological scores of the organs were shown in Table 6 . There was a negative correlation between pathological scores and Flt-1 levels in the liver (r=-0.522). This correlation was statistically significant (p=0.011). There were positive correlations between pathological scores and VEGF levels (r=0.477), VEGF/ Flt-1(r=0.529) ratios in kidneys. These correlations were statistically significant (p=0.009), (p=0.021). There was no statically significant correlation between pathological scores in remote organs and serum levels of VEGF, Flt-1, and VEGF/ Flt-1 ratios. in remote organ injury such as that in the liver and kidneys. [16, 40] MDA is an end product of lipid peroxidation and known as a good indicator of cell destruction due to oxidative and nitrosative damage. [1] VEGF is a mediator of angiogenesis and may also have a role in inflammation; [21, 41] moreover, NO and VEGF may interact to promote angiogenesis. [42] However, the results showed that a high concentration of NO donors downregulates VEGF expression in endothelial cells. [43] On the other hand, previous studies show endogenous NO enhances VEGF synthesis. [23, 43, 44] NO is known as an inducer of VEGF synthesis under normoxia. However, why NO shows conflicting effects on VEGF is still unclear. An optimal amount of NO may upregulate the VEGF in limited cell lines while an excessive amount of NO inhibits the VEGF expression through an unidentified pathway. [20] All this information reveals that VEGF governs the controlled and regulated phenomenon of angiogenesis, whereas it may also have a role in inflammation dependent remote organ injury. Additionally, Flt-1 is known as a VEGF decoy receptor, serving to spatially control VEGF signaling and formation of angiogenic sprouts and in addition to its negative regulatory role in vascular development, Flt-1 is important in mounting an inflammatory response and inflammation-associated angiogenesis (denoted 'pathological angiogenesis') through recruitment of bone marrow-derived myelomonocytic cells followed by deposition of angiogenic growth factors. [22] Increase of Gpx enzyme activities following burn related injury protects tissues from the effects of free radicals and lipid peroxidation. [44] TOS and TAC parameters instead of individual oxidant and antioxidant compounds such as MDA, Gpx, and Cat acting in combination with each other may reflect the total effect of oxidant and antioxidant balance in tissues and serum levels. The definition of oxidative stress index (OSI)
DISCUSSION
shows either increased oxidant production or a decreased antioxidant capacity in cells characterized by the release of free radicals, resulting in cellular degeneration which reflects TOS vs TAC ratio. [38, 45] In the present study, we specified that sildenafil may have protective effects against severe burn-induced remote organ injury decreasing oxidative and nitrosative stress, as confirmed by biochemical assays and histopathological analysis in both tissues and serum. Our findings fairly presented that treatment with sildenafil increased Gpx and TAC, and decreased MDA, TOS, and OSI. Another important result of our study was that sildenafil had beneficial effects on decreasing the inflammation scores in tissues. Additionally, the 10 mg/kg sildenafil group had the lowest inflammation scores in both liver and kidneys, in our study. However, no additional benefit was pointed out when the dosage increased to 20 mg/kg. The effects of sildenafil treatment on VEGF and Flt-1 in tissue levels appear to be dependent upon dosage and organ. On the other hand, sildenafil treatment appears to be effective on VEGF serum levels through Flt-1. As in previous studies, [17, 20, 23] sildenafil showed conflicting effects in VEGF values in tissues in our study and these effects may be due to the amount of NO produced by sildenafil. However, not measuring the levels of NO can be accepted as a limitation of this trial.
Cadirci et al. [32] reported effects of sildenafil (10 and 20 mg/ kg/p.o.) in remote organs, including the lung and kidneys, in a rat model of sepsis. They observed a significant decrease in oxidative stress and inflammation degree by evaluating similar biochemical parameters and histopathological scores, like ours, in the sildenafil-treated groups compared to the control group. However, unlike us, they evaluated the oxidant/antioxidant parameters in only tissue levels, whereas we evaluated them in both tissues and serum. Similarly, Uzun et al. [34] Ulus Travma Acil Cerrahi Derg, September 2014, Vol. 20, No. 5
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Gökakın et al. The effects of sildenafil in liver and kidney injury in a rat model of severe scald burn demonstrated that sildenafil administration (10 mg/kg/p.o.) in ischemic colonic anastomoses increased GSH levels and promoted healing of anastomosis. Additionally, Iseri et al. [33] found that sildenafil treatment (5 mg/kg/p.o.) decreased MDA and increased GSH levels in tissues and improved the healing of colonic inflammation in rats. Also, in a different trial, Karakoyun et al. [31] concluded in rat experimentally induced colitis that sildenafil treatment (25 mg/kg/p.o.) decreased MDA and increased GSH levels in colonic tissues and might have a beneficial effect in colitis treatment. Additionally, Zhang et al. [23] used sildenafil treatment (2 mg/kg/p.o.) in a rat model of brain ischemia and found out that sildenafil promoted angiogenesis via VEGF. These results supported the findings of the present study and demonstrated positive effects of different dosages of sildenafil treatment on different tissue injuries due to oxidative and nitrosative stress.
In our review of the literature, we were not able to find any previous experimental study using TAC, TOS, and OSI levels to evaluate the oxidative stress in both tissues and serum except our previous study. [9] In our study, while TAC levels in liver tissues were found to be higher, TOS and OSI levels were found to be lower in treatment groups. A similar trend was found in the kidneys, but was not statistically significant. This situation may be accepted as additional evidence for the beneficial effects of sildenafil in tissue levels. Sildenafil seems to have dose dependent positive effects only on TAC levels in terms of serum levels.
Positive effects of sildenafil administration in histopathological evaluations in inflammatory events have been demonstrated in a number of previous studies. [23, [30] [31] [32] [33] [34] 46, 47] Histopathological evaluations of those studies also demonstrated the positive effects of various dosages of sildenafil administration (range 2±25 mg/kg) in decreased inflammation scores.
In conclusion, our findings reveal that sildenafil may have a protective effect in scald burn-related remote organ injury by decreasing oxidative and nitrosative stress, as well as inflammation. In addition, the dosage of 10 mg/kg appears better than 20 mg/kg.
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